Now Approved: U.S. FDA approves product to reduce the incidence of catheter-related bloodstream infections (CRBSIs) under special pathway for patients receiving hemodialysis.

Liz Hurlburt

September 1, 2022

Liz Masson Hurlburt serves as our Executive Vice President of Clinical & Medical Affairs. Prior to that, she held several progressive management roles in clinical operations, most recently at Gemphire Therapeutics, as Vice President, Clinical Operations. Responsible for strategic and clinical development activities, Liz has a passion for growing and developing highly engaged teams and assuring the highest standards for medical affairs and clinical development execution. Liz received her B.A. in Leadership and Organizational Management from Bay Path College and a Master’s in Management and Leadership from Western Governors University.